阿克比亞治療公司
US ˙ NasdaqCM ˙ US00972D1054

簡介

本頁面提供了有關 Butler John P. 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Butler John P.已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:AKBA / Akebia Therapeutics, Inc. CEO and President, Director 3,367,064
US:ZYNE / Zynerba Pharmaceuticals Inc Director 0
US:KERX / Keryx Biopharmaceuticals, Inc. Director 30,000
US:RLYP / Relypsa, Inc. Director 0
如何解讀這些圖表

以下圖表顯示了在Butler John P.進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

AKBA / Akebia Therapeutics, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 AKBA / Akebia Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2026-03-04 AKBA Butler John P. 69,270 1.2500 69,270 1.2500 86,588 41 1.5600 21,474 24.80
2019-11-20 AKBA Butler John P. 50,000 3.4400 50,000 3.4400 172,000
2014-11-12 AKBA Butler John P. 1,000 10.3050 1,000 10.3050 10,305
2014-03-25 AKBA Butler John P. 13,850 17.0000 13,850 17.0000 235,450

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AKBA / Akebia Therapeutics, Inc. Insider Trades
AKBA / Akebia Therapeutics, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 AKBA / Akebia Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2024-02-29 AKBA Butler John P. 46,570 1.5800 46,570 1.5800 73,581 117 0.8567 -33,683 -45.78
2024-02-27 AKBA Butler John P. 37,733 1.5200 37,733 1.5200 57,354
2024-02-01 AKBA Butler John P. 46,489 1.6800 46,489 1.6800 78,102
2023-03-01 AKBA Butler John P. 38,259 0.8775 38,259 0.8775 33,572
2023-03-01 AKBA Butler John P. 47,239 0.8775 47,239 0.8775 41,452
2023-03-01 AKBA Butler John P. 6,370 0.8775 6,370 0.8775 5,590
2023-02-27 AKBA Butler John P. 38,632 0.8132 38,632 0.8132 31,416
2022-03-01 AKBA Butler John P. 24,811 2.1707 24,811 2.1707 53,857
2022-03-01 AKBA Butler John P. 25,031 2.1707 25,031 2.1707 54,335
2022-03-01 AKBA Butler John P. 4,131 2.1707 4,131 2.1707 8,967
2022-02-28 AKBA Butler John P. 25,053 2.1548 25,053 2.1548 53,984
2021-04-01 AKBA Butler John P. 4,109 3.4000 4,109 3.4000 13,971
2021-03-01 AKBA Butler John P. 25,316 3.3961 25,316 3.3961 85,976
2021-03-01 AKBA Butler John P. 24,674 3.3961 24,674 3.3961 83,795

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AKBA / Akebia Therapeutics, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Butler John P. 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-03-05 2026-03-04 4 AKBA Akebia Therapeutics, Inc.
Common Stock
P - Purchase 69,270 3,367,064 2.10 1.25 86,588 4,208,830
2026-02-04 2026-02-02 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale X -83,689 3,297,794 -2.47 1.39 -116,328 4,583,934
2026-02-04 2026-02-02 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 175,250 3,381,483 5.47 1.41 247,102 4,767,891
2026-02-04 2026-02-02 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale X -114,891 3,206,233 -3.46 1.39 -159,698 4,456,664
2026-02-04 2026-02-02 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale X -96,065 3,321,124 -2.81 1.39 -133,530 4,616,362
2026-02-04 2026-02-02 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale X -46,660 3,417,189 -1.35 1.39 -64,857 4,749,893
2026-02-03 2026-01-30 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 743,000 3,463,849 27.31
2025-03-04 2025-03-03 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale X -46,409 2,557,921 -1.78 1.83 -84,928 4,680,995
2025-02-04 2025-02-03 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale X -97,982 2,604,330 -3.63 2.10 -205,762 5,469,093
2025-02-04 2025-02-03 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale X -46,268 2,702,312 -1.68 2.10 -97,163 5,674,855
2025-02-04 2025-01-31 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 701,000 2,748,580 34.24
2024-03-01 2024-02-29 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -46,570 2,044,580 -2.23 1.58 -73,581 3,230,436
2024-02-29 2024-02-27 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -37,733 2,091,150 -1.77 1.52 -57,354 3,178,548
2024-02-02 2024-02-01 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -46,489 2,128,883 -2.14 1.68 -78,102 3,576,523
2024-02-02 2024-01-31 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 603,500 2,175,372 38.39
2023-10-11 2023-10-10 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
U - Other -47,824 0 -100.00
2023-10-11 2023-10-10 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
U - Other -32,941 47,824 -40.79
2023-06-15 2023-06-14 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
S - Sale -115 80,765 -0.14 0.35 -40 28,114
2023-06-15 2023-06-13 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
A - Award 47,824 80,880 144.68
2023-03-03 2023-03-01 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -6,370 1,568,872 -0.40 0.88 -5,590 1,376,685
2023-03-03 2023-03-01 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -47,239 1,575,242 -2.91 0.88 -41,452 1,382,275
2023-03-03 2023-03-01 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -38,259 1,622,481 -2.30 0.88 -33,572 1,423,727
2023-03-01 2023-02-27 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -38,632 1,660,740 -2.27 0.81 -31,416 1,350,514
2023-02-02 2023-01-31 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 293,125 1,699,372 20.84
2022-06-16 2022-06-14 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
S - Sale -53 33,056 -0.16 1.01 -54 33,387
2022-06-16 2022-06-14 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
A - Award 23,109 33,109 231.09
2022-03-02 2022-03-01 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -4,131 1,403,247 -0.29 2.17 -8,967 3,046,028
2022-03-02 2022-03-01 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -25,031 1,407,378 -1.75 2.17 -54,335 3,054,995
2022-03-02 2022-03-01 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -24,811 1,432,409 -1.70 2.17 -53,857 3,109,330
2022-03-02 2022-02-28 4 AKBA Akebia Therapeutics, Inc.
Employee Stock Option (Right to buy)
A - Award 739,700 739,700
2022-03-02 2022-02-28 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 293,125 1,457,220 25.18
2022-03-02 2022-02-28 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -25,053 1,164,095 -2.11 2.15 -53,984 2,508,392
2022-02-18 2018-12-12 4/A AKBA Akebia Therapeutics, Inc.
Common Stock
J - Other 1,248 375,865 0.33
2021-08-05 2021-08-03 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7,500 7,500
2021-08-05 2021-08-03 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
A - Award 5,000 10,000 100.00
2021-04-01 2021-04-01 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -4,109 1,152,153 -0.36 3.40 -13,971 3,917,320
2021-03-18 2021-03-16 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 39,520 1,156,262 3.54
2021-03-02 2021-03-01 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -24,674 1,116,742 -2.16 3.40 -83,795 3,792,568
2021-03-02 2021-03-01 4 AKBA Akebia Therapeutics, Inc.
Common Stock
S - Sale -25,316 1,141,416 -2.17 3.40 -85,976 3,876,363
2021-03-02 2021-02-26 4 AKBA Akebia Therapeutics, Inc.
Employee Stock Option (Right to buy)
A - Award 403,600 403,600
2021-03-02 2021-02-26 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 237,400 1,166,732 25.55
2020-06-11 2020-06-10 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2020-03-02 2020-02-28 4 AKBA Akebia Therapeutics, Inc.
Stock Option (Right to buy)
A - Award 403,600 403,600
2020-03-02 2020-02-28 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 237,400 1,026,632 30.08
2019-11-21 2019-11-20 4 AKBA Akebia Therapeutics, Inc.
Common Stock
P - Purchase 50,000 887,732 5.97 3.44 172,000 3,053,798
2019-06-13 2019-06-11 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2019-06-05 2019-06-03 4 AKBA Akebia Therapeutics, Inc.
Employee Stock Option (Right to buy)
M - Exercise -287,000 0 -100.00
2019-06-05 2019-06-03 4 AKBA Akebia Therapeutics, Inc.
Common Stock
M - Exercise 287,000 836,232 52.25 0.47 134,890 393,029
2019-03-05 2019-02-28 4 AKBA Akebia Therapeutics, Inc.
Employee Stock Option (Right to buy)
A - Award 350,000 350,000
2019-03-05 2019-02-28 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 239,500 614,382 63.89
2018-12-13 2018-12-12 4 AKBA Akebia Therapeutics, Inc.
Common Stock
F - Taxes -135,697 374,617 -26.59 8.94 -1,213,131 3,349,076
2018-08-22 2018-08-22 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
P - Purchase 5,000 5,000 6.43 32,153 32,153
2018-07-12 2018-07-11 4 AKBA Akebia Therapeutics, Inc.
Employee Stock Option (Right to buy)
M - Exercise -100,000 287,000 -25.84
2018-07-12 2018-07-11 4 AKBA Akebia Therapeutics, Inc.
Common Stock
M - Exercise 100,000 510,314 24.37 0.47 47,000 239,848
2018-06-07 2018-06-06 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2018-04-16 2018-04-12 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 35,000 35,000
2018-03-02 2018-02-28 4 AKBA Akebia Therapeutics, Inc.
Employee Stock Option (Right to buy)
A - Award 126,300 126,300
2018-03-02 2018-02-28 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 88,900 408,814 27.79
2017-06-20 2017-06-09 4 KERX KERYX BIOPHARMACEUTICALS INC
Stock Options (right to buy)
A - Award 30,000 30,000
2017-06-20 2017-06-09 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
A - Award 10,000 20,000 100.00
2017-02-23 2017-02-21 4 AKBA Akebia Therapeutics, Inc.
Stock Option (Right to buy)
A - Award 190,000 190,000 10.14 1,926,600 1,926,600
2017-02-23 2017-02-21 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 119,500 317,780 60.27
2017-02-10 2016-07-28 5 AKBA Akebia Therapeutics, Inc.
Common Stock
G - Gift 58,400 58,400
2017-02-10 2016-07-28 5 AKBA Akebia Therapeutics, Inc.
Common Stock
G - Gift -116,800 198,280 -37.07
2017-01-23 2017-01-19 4 AKBA Akebia Therapeutics, Inc.
Stock Option (Right to buy)
M - Exercise -20,000 387,000 -4.91
2017-01-23 2017-01-19 4 AKBA Akebia Therapeutics, Inc.
Common Stock
M - Exercise 20,000 373,480 5.66 0.47 9,400 175,536
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
D - Sale to Issuer -4,500 0 -100.00
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
D - Sale to Issuer -4,500 0 -100.00
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
D - Sale to Issuer -3,828 0 -100.00
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
D - Sale to Issuer -24,632 0 -100.00
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Common Stock
D - Sale to Issuer -2,250 0 -100.00 32.00 -72,000
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Common Stock
U - Other -2,849 2,250 -55.87 32.00 -91,168 72,000
2016-06-23 2016-06-21 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
A - Award 4,500 4,500
2016-06-23 2016-06-21 4 RLYP Relypsa Inc
Common Stock
A - Award 2,250 5,099 78.98
2016-06-08 2016-06-07 4 RLYP Relypsa Inc
Common Stock
S - Sale -1,013 2,849 -26.23 19.32 -19,570 55,040
2016-05-27 2016-05-26 4 KERX KERYX BIOPHARMACEUTICALS INC
Stock Options (right to buy)
A - Award 30,000 30,000
2016-05-27 2016-05-26 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
A - Award 10,000 10,000
2016-02-24 2016-02-22 4 AKBA Akebia Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award -190,550 190,550 -50.00
2016-02-24 2016-02-22 4 AKBA Akebia Therapeutics, Inc.
Common Stock
A - Award 125,500 351,173 55.61
2016-01-19 2016-01-15 4 AKBA Akebia Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -25,000 407,000 -5.79
2016-01-19 2016-01-15 4 AKBA Akebia Therapeutics, Inc.
Common Stock
M - Exercise 25,000 225,673 12.46 0.47 11,750 106,066
2015-12-10 3 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock (Restricted)
20,000
2015-12-10 3 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock (Restricted)
20,000
2015-06-15 2015-06-11 4 RLYP Relypsa Inc
Common Stock
S - Sale X -1,100 3,862 -22.17 34.62 -38,087 133,718
2015-06-08 2015-06-04 4 RLYP Relypsa Inc
Stock Option (right to buy)
A - Award 4,500 4,500
2015-06-08 2015-06-04 4 RLYP Relypsa Inc
Common Stock
A - Award 2,250 4,962 82.96
2015-05-28 2015-05-26 4 AKBA Akebia Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -50,000 0 -100.00
2015-05-28 2015-05-26 4 AKBA Akebia Therapeutics, Inc.
Common Stock
M - Exercise 50,000 198,350 33.70 0.47 23,500 93,224
2015-03-11 2015-03-09 4 AKBA Akebia Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -100,000 0 -100.00
2015-03-11 2015-03-09 4 AKBA Akebia Therapeutics, Inc.
Common Stock
M - Exercise 100,000 148,350 206.83 0.47 47,000 69,724
2015-03-10 2015-03-06 4 AKBA Akebia Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 150,000 150,000
2014-12-29 2014-12-29 4 AKBA Akebia Therapeutics, Inc.
Common Stock
P - Purchase X 1,000 48,350 2.11 11.57 11,567 559,274
2014-12-22 2014-12-22 4 AKBA Akebia Therapeutics, Inc.
Common Stock
P - Purchase X 1,000 47,350 2.16 11.92 11,916 564,223
2014-12-18 2014-12-15 4 AKBA Akebia Therapeutics, Inc.
Common Stock
P - Purchase X 1,000 46,350 2.21 11.34 11,336 525,442
2014-11-13 2014-11-12 4 AKBA Akebia Therapeutics, Inc.
Common Stock
P - Purchase 1,000 45,350 2.25 10.30 10,305 467,332
2014-11-13 2014-11-11 4 AKBA Akebia Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -30,500 0 -100.00
2014-11-13 2014-11-11 4 AKBA Akebia Therapeutics, Inc.
Common Stock
M - Exercise 30,500 44,350 220.22 0.47 14,335 20,844
2014-08-05 2014-05-14 4 AKBA Akebia Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 46,667 46,667
2014-06-23 2014-06-19 4 RLYP Relypsa Inc
Stock Option (right to buy)
A - Award 3,828 3,828
2014-06-23 2014-06-19 4 RLYP Relypsa Inc
Common Stock
A - Award 2,712 2,712
2014-03-27 2014-03-25 4 AKBA Akebia Therapeutics, Inc.
Common Stock
P - Purchase 13,850 13,850 17.00 235,450 235,450
2013-11-18 2013-11-14 4 RLYP Relypsa Inc
Stock Option (right to buy)
A - Award 8,247 8,247
2013-11-18 2013-11-14 4 RLYP Relypsa Inc
Stock Option (right to buy)
A - Award 16,385 16,385
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)